The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(2-chloro-4-((2-morpholinoethyl)amino)phenyl)-5-(trifluoromethyl)pyridin-2(1H)-one ID: ALA4776146
PubChem CID: 49820718
Max Phase: Preclinical
Molecular Formula: C18H19ClF3N3O2
Molecular Weight: 401.82
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=c1ccc(C(F)(F)F)cn1-c1ccc(NCCN2CCOCC2)cc1Cl
Standard InChI: InChI=1S/C18H19ClF3N3O2/c19-15-11-14(23-5-6-24-7-9-27-10-8-24)2-3-16(15)25-12-13(18(20,21)22)1-4-17(25)26/h1-4,11-12,23H,5-10H2
Standard InChI Key: ZHNYJLYSBGBBJP-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
39.6427 -4.2058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6425 -3.3886 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.9347 -2.9802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3501 -2.9798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9345 -2.1630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3499 -2.1626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6421 -1.7542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0579 -3.3882 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.2267 -1.7545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2265 -0.9374 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
37.5191 -2.1633 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
37.5165 -1.3455 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
38.9326 -4.6121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9324 -5.4285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6408 -5.8377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3507 -5.4246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3474 -4.6095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2257 -4.2020 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
39.6420 -6.6549 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.3504 -7.0624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0574 -6.6527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.7658 -7.0602 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.4729 -6.6505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.7671 -7.8774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.1812 -7.0580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.1825 -7.8752 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
42.4754 -8.2849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
2 4 1 0
3 5 2 0
4 6 1 0
5 7 1 0
6 7 2 0
4 8 2 0
5 9 1 0
9 10 1 0
9 11 1 0
9 12 1 0
1 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 1 1 0
13 18 1 0
15 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
22 24 1 0
23 25 1 0
24 27 1 0
25 26 1 0
26 27 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 401.82Molecular Weight (Monoisotopic): 401.1118AlogP: 3.25#Rotatable Bonds: 5Polar Surface Area: 46.50Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.69CX LogP: 2.38CX LogD: 2.31Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.84Np Likeness Score: -1.95
References 1. Chen J,Peng Z,Lu M,Xiong X,Chen Z,Li Q,Cheng Z,Jiang D,Tao L,Hu G. (2018) Discovery of 1-(4-((3-(4-methylpiperazin-1-yl)propyl)amino)benzyl)-5-(trifluoromethyl)pyridin-2(1H)-one, an orally active multi-target agent for the treatment of diabetic nephropathy., 28 (2): [PMID:29248299 ] [10.1016/j.bmcl.2017.07.001 ]